MYGNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
MYRIAD GENETICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$4.21+0.23 (+5.78%)
Close on Oct 19, 2026
- Market cap
- $399.11M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
94.1%
90M of 96M shares
Institutional holders
197
44 new, 45 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
5 buys · 1 sales
Net bought $655.32K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 9,900,937 | 10.40% | 13G (passive) | Aug 31, 2026 |
| BlackRock, Inc. | 7,976,163 | 8.50% | 13G (passive) amendment | Mar 31, 2026 |
| Millennium Management LLC | 6,700,158 | 7.20% | 13G (passive) amendment | Dec 31, 2025 |
| Wellington Management Company LLP | 6,004,598 | 6.00% | 13G (passive) amendment | Dec 31, 2024 |
| Ryan Wilder | 5,735,000 | 6.10% | 13G (passive) | Jun 30, 2026 |
| State Street Corporation | 4,985,060 | 5.30% | 13G (passive) | Jun 30, 2026 |
| Robbins Larry | 4,941,058 | 5.30% | 13G (passive) | Jan 6, 2026 |
| Millennium Group Management LLC | 4,748,327 | 5.10% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MYGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,890,440 | 11.39% | $62.18M | +2,000,796 | 0.00% |
| Millennium Management LLC | 6,620,372 | 6.92% | $37.80M | −48,445 | 0.01% |
| Vestal Point Capital, LP | 5,735,000 | 6.00% | $32.75M | +4,087,000 | 0.77% |
| State Street Corp | 4,985,060 | 5.21% | $28.46M | +561,033 | 0.00% |
| D. E. Shaw & Co., Inc. | 4,582,083 | 4.79% | $26.16M | +82,359 | 0.01% |
| Vanguard Capital Management LLC | 4,081,376 | 4.27% | $23.30M | +156,851 | 0.00% |
| Acadian Asset Management LLC | 3,126,973 | 3.27% | $17.84K | +818,384 | 0.02% |
| Vanguard Portfolio Management LLC | 3,079,670 | 3.22% | $17.58M | +497,439 | 0.00% |
| Aqr Capital Management LLC | 2,766,689 | 2.89% | $15.80M | +854,393 | 0.01% |
| Morgan Stanley | 2,481,104 | 2.59% | $14.17M | −687,638 | 0.00% |
| Geode Capital Management, LLC | 2,416,197 | 2.53% | $13.80M | +96,818 | 0.00% |
| Assenagon Asset Management S.A. | 2,062,928 | 2.16% | $11.78M | +615,967 | 0.01% |
| Goldman Sachs Group Inc | 2,056,843 | 2.15% | $11.74M | −309,249 | 0.00% |
| Jacobs Levy Equity Management, Inc | 1,891,527 | 1.98% | $10.80M | −196,965 | 0.04% |
| Charles Schwab Investment Management Inc | 1,740,794 | 1.82% | $9.94M | −60,684 | 0.00% |
| Qube Research & Technologies Ltd | 1,665,835 | 1.74% | $9.51M | −24,626 | 0.01% |
| Federated Hermes, Inc. | 1,570,314 | 1.64% | $8.97M | −405,852 | 0.01% |
| Two Sigma Investments, LP | 1,557,727 | 1.63% | $8.89M | +273,677 | 0.01% |
| Nuveen, LLC | 1,545,549 | 1.62% | $8.83M | +626,586 | 0.00% |
| Mackenzie Financial Corp | 1,535,702 | 1.61% | $8.77M | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 197 | 90M | 94.1% | 44 / 76 | 58 / 45 | 20M | 18M |
| Q1 2026 | 203 | 88M | 92.1% | 33 / 75 | 68 / 48 | 21M | 16M |
| Q4 2025 | 221 | 92M | 96.4% | 31 / 85 | 75 / 26 | 10M | 6M |
| Q3 2025 | 221 | 89M | 93.1% | 41 / 77 | 69 / 37 | 13M | 13M |
| Q2 2025 | 221 | 90M | 94.6% | 43 / 91 | 53 / 49 | 23M | 27M |
| Q1 2025 | 228 | 94M | 98.3% | 38 / 79 | 78 / 29 | 10M | 8M |
| Q4 2024 | 221 | 92M | 96.7% | 33 / 91 | 74 / 57 | 11M | 10M |
| Q3 2024 | 246 | 91M | 95.4% | 48 / 85 | 72 / 23 | 23M | 10M |
| Q2 2024 | 223 | 93M | 97.0% | 54 / 72 | 64 / 15 | 7M | 11M |
| Q1 2024 | 186 | 97M | 100.0% | 21 / 73 | 62 / 29 | 9M | 3M |
| Q4 2023 | 194 | 91M | 95.0% | 28 / 78 | 61 / 19 | 11M | 2M |
| Q3 2023 | 186 | 83M | 86.5% | 16 / 69 | 72 / 17 | 6M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MYGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 3,015,479 | 3.15% | $17.22M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 2,881,677 | 3.01% | $16.45M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,415,960 | 2.53% | $13.80M | 0.02% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund | 1,230,530 | 1.29% | $3.52M | 0.09% | Jul 31, 2026 |
| Federated Hermes MDT Small Cap Core Fund | 1,116,258 | 1.17% | $3.19M | 0.14% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,109,086 | 1.16% | $6.33M | 0.01% | Jun 30, 2026 |
| Vanguard Strategic Equity Fund | 1,021,536 | 1.07% | $5.83M | 0.05% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,009,496 | 1.06% | $2.89M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 859,842 | 0.90% | $4.91M | 0.03% | Jun 30, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 682,873 | 0.71% | $3.90M | 0.12% | Jun 30, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 668,525 | 0.70% | $3.82M | 0.07% | Jun 30, 2026 |
| iShares Biotechnology ETF | 623,865 | 0.65% | $3.56M | 0.04% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 492,881 | 0.52% | $1.96M | 0.02% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 471,590 | 0.49% | $1.87M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 443,693 | 0.46% | $1.76M | 0.01% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Samraat S. Raha | President and CEO, Director | 1,068,083 | 1.12% | Jun 12, 2026 |
| Paul J. Diaz | President and CEO, Director | 891,844 | 0.93% | Apr 30, 2025 |
| Benjamin Richard Wheeler | Chief Financial Officer | 287,193 | 0.30% | Sep 22, 2026 |
| Brian J. Donnelly | Chief Commercial Officer | 573,363 | 0.60% | Sep 18, 2026 |
| Vishal Sikri | EVP, Commercial | 93,493 | 0.10% | Sep 17, 2026 |
| Jennifer Lynne Fox | Chief Legal Officer | 305,964 | 0.32% | Sep 8, 2026 |
| Raj Jampa | Chief Technology Officer | 251,889 | 0.26% | Jun 2, 2026 |
| Mark Verratti | Chief Operating Officer | 629,646 | 0.66% | Apr 15, 2026 |
| Dale Muzzey | Chief Scientific Officer | 326,310 | 0.34% | Apr 15, 2026 |
| Kevin Richard Haas | Chief Technology Officer | 188,404 | 0.20% | Mar 16, 2026 |
| Shereen Solaiman | Chief People Officer | 267,801 | 0.28% | Mar 16, 2026 |
| Margaret Ancona | EVP, Strategy & Transformation | 127,726 | 0.13% | Nov 4, 2025 |
| Natalie Munk | Chief Accounting Officer | 45,167 | 0.05% | Oct 24, 2025 |
| Scott J. Leffler | Chief Financial Officer | 218,393 | 0.23% | Aug 18, 2025 |
| Daniel Skovronsky | Director | 195,507 | 0.20% | Jun 23, 2026 |
| Rashmi Kumar | Director | 171,889 | 0.18% | Jun 9, 2026 |
| S. Louise Phanstiel | Director | 374,771 | 0.39% | Jun 5, 2026 |
| Paul Bisaro | Director | 157,142 | 0.16% | Jun 5, 2026 |
| Colleen F. Reitan | Director | 152,030 | 0.16% | Jun 5, 2026 |
| Lee Nisley Newcomer | Director | 191,842 | 0.20% | Jun 5, 2026 |
| Mark Steven Davis | Director | 106,665 | 0.11% | Jun 5, 2026 |
| Heinrich Dreismann | Director | 231,145 | 0.24% | Jun 5, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Benjamin Richard Wheeler Chief Financial Officer | Sep 21, 2026 | Tax withholding | −2,555 | $4.01 | $10.25K | 287,193 |
| Vishal Sikri EVP, Commercial | Sep 16, 2026 | Award | +257,731 | – | – | 351,224 |
| Jennifer Lynne Fox Chief Legal Officer | Sep 3, 2026 | Tax withholding | −4,398 | $3.23 | $14.21K | 305,964 |
| Benjamin Richard Wheeler Chief Financial Officer | Aug 16, 2026 | Tax withholding | −8,761 | $3.03 | $26.55K | 289,748 |
| Samraat S. Raha President and CEO, Director | Jun 11, 2026 | Award | +3,542 | $3.94 | $13.96K | 1,068,083 |
| Brian J. Donnelly Chief Commerical Officer | Jun 11, 2026 | Award | +5,000 | $3.94 | $19.70K | 573,363 |
| Rashmi Kumar Director | Jun 8, 2026 | Sale(10b5-1 plan) | −15,000 | $4.46 | $66.90K | 171,889 |
| Rashmi Kumar Director | Jun 4, 2026 | Award | +59,701 | – | – | 186,889 |
| Paul Bisaro Director | Jun 4, 2026 | Award | +59,701 | – | – | 157,142 |
| Colleen F. Reitan Director | Jun 4, 2026 | Award | +59,701 | – | – | 152,030 |
| Daniel Skovronsky Director | Jun 4, 2026 | Award | +59,701 | – | – | 195,507 |
| Lee Nisley Newcomer Director | Jun 4, 2026 | Award | +59,701 | – | – | 191,842 |
| Heinrich Dreismann Director | Jun 4, 2026 | Award | +59,701 | – | – | 231,145 |
| S. Louise Phanstiel Director | Jun 4, 2026 | Award | +59,701 | – | – | 341,652 |
| Mark Steven Davis Director | Jun 4, 2026 | Award | +59,701 | – | – | 106,665 |
| Raj Jampa Chief Technology Officer | Jun 1, 2026 | Award | +251,889 | – | – | 251,889 |
| Paul Bisaro Director | May 14, 2026 | Buy | +7,500 | $3.69 | $27.68K | 97,441 |
| Brian J. Donnelly Chief Commerical Officer | May 1, 2026 | Tax withholding | −55,975 | $4.80 | $268.68K | 568,363 |
| Mark Verratti Chief Operating Officer | Apr 14, 2026 | Tax withholding | −1,069 | $4.91 | $5.25K | 629,646 |
| Dale Muzzey Chief Scientific Officer | Apr 14, 2026 | Tax withholding | −946 | $4.91 | $4.64K | 326,310 |
| Dale Muzzey Chief Scientific Officer | Mar 22, 2026 | Tax withholding | −2,019 | $4.58 | $9.25K | 327,256 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 22, 2026 | Tax withholding | −549 | $4.58 | $2.51K | 298,509 |
| Mark Verratti Chief Operating Officer | Mar 22, 2026 | Tax withholding | −2,055 | $4.58 | $9.41K | 630,715 |
| Dale Muzzey Chief Scientific Officer | Mar 15, 2026 | Tax withholding | −11,949 | $4.66 | $55.68K | 329,275 |
| Dale Muzzey Chief Scientific Officer | Mar 15, 2026 | Tax withholding | −4,783 | $4.66 | $22.29K | 341,224 |
| Mark Verratti Chief Operating Officer | Mar 15, 2026 | Tax withholding | −5,611 | $4.66 | $26.15K | 641,866 |
| Mark Verratti Chief Operating Officer | Mar 15, 2026 | Tax withholding | −9,096 | $4.66 | $42.39K | 632,770 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 15, 2026 | Tax withholding | −877 | $4.66 | $4.09K | 301,250 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 15, 2026 | Tax withholding | −2,192 | $4.66 | $10.21K | 299,058 |
| Kevin Richard Haas Chief Technology Officer | Mar 15, 2026 | Tax withholding | −3,355 | $4.66 | $15.63K | 188,404 |
| Kevin Richard Haas Chief Technology Officer | Mar 15, 2026 | Tax withholding | −8,382 | $4.66 | $39.06K | 180,022 |
| Dale Muzzey Chief Scientific Officer | Mar 14, 2026 | Tax withholding | −8,288 | $4.66 | $38.62K | 346,007 |
| Shereen Solaiman Chief People Officer | Mar 14, 2026 | Tax withholding | −5,784 | $4.66 | $26.95K | 267,801 |
| Mark Verratti Chief Operating Officer | Mar 14, 2026 | Tax withholding | −5,418 | $4.66 | $25.25K | 647,477 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 14, 2026 | Tax withholding | −1,097 | $4.66 | $5.11K | 302,127 |
| Samraat S. Raha President and CEO, Director | Mar 14, 2026 | Tax withholding | −10,816 | $4.66 | $50.40K | 1,064,541 |
| Kevin Richard Haas Chief Technology Officer | Mar 14, 2026 | Tax withholding | −4,161 | $4.66 | $19.39K | 191,759 |
| Dale Muzzey Chief Scientific Officer | Mar 13, 2026 | Tax withholding | −12,779 | $4.66 | $59.55K | 354,295 |
| Shereen Solaiman Chief People Officer | Mar 13, 2026 | Tax withholding | −8,899 | $4.66 | $41.47K | 273,585 |
| Mark Verratti Chief Operating Officer | Mar 13, 2026 | Tax withholding | −9,164 | $4.66 | $42.70K | 652,895 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 13, 2026 | Tax withholding | −586 | $4.66 | $2.73K | 303,224 |
| Jennifer Lynne Fox Chief Legal Officer | Mar 13, 2026 | Tax withholding | −5,995 | $4.66 | $27.94K | 310,362 |
| Samraat S. Raha President and CEO, Director | Mar 13, 2026 | Tax withholding | −36,304 | $4.66 | $169.18K | 1,075,357 |
| Kevin Richard Haas Chief Technology Officer | Mar 13, 2026 | Tax withholding | −6,412 | $4.66 | $29.88K | 195,920 |
| Dale Muzzey Chief Scientific Officer | Mar 12, 2026 | Award | +173,196 | – | – | 367,074 |
| Shereen Solaiman Chief People Officer | Mar 12, 2026 | Award | +173,196 | – | – | 282,484 |
| Mark Verratti Chief Operating Officer | Mar 12, 2026 | Award | +247,423 | – | – | 662,059 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 12, 2026 | Award | +206,186 | – | – | 303,810 |
| Brian J. Donnelly Chief Commerical Officer | Mar 12, 2026 | Award | +226,804 | – | – | 624,338 |
| Jennifer Lynne Fox Chief Legal Officer | Mar 12, 2026 | Award | +195,876 | – | – | 316,357 |
| Samraat S. Raha President and CEO, Director | Mar 12, 2026 | Award | +618,557 | – | – | 1,111,661 |
| Samraat S. Raha President and CEO, Director | Mar 9, 2026 | Buy | +40,000 | $5.00 | $200.00K | 493,104 |
| Shereen Solaiman Chief People Officer | Mar 1, 2026 | Tax withholding | −1,675 | $4.61 | $7.72K | 109,288 |
| S. Louise Phanstiel Director | Feb 27, 2026 | Buy | +48,000 | $4.66 | $223.68K | 281,951 |
| S. Louise Phanstiel Director | Feb 26, 2026 | Buy | +50,407 | $4.80 | $241.95K | 233,951 |
| S. Louise Phanstiel Director | Feb 25, 2026 | Buy | +6,100 | $4.74 | $28.91K | 183,544 |
| Dale Muzzey Chief Scientific Officer | Feb 2, 2026 | Award | +23,697 | – | – | 193,878 |
| Kevin Richard Haas Chief Technology Officer | Feb 2, 2026 | Award | +23,697 | – | – | 202,332 |
| Benjamin Richard Wheeler Chief Financial Officer | Feb 2, 2026 | Award | +4,994 | – | – | 97,624 |
| Mark Verratti Chief Operating Officer | Feb 2, 2026 | Award | +32,810 | – | – | 414,636 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Rashmi Kumar Director | Jun 8, 2026 | 15,000 | $68.85K | Jun 8, 2026 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | Oct 11, 2024 | 15,000 | $343.95K | Oct 11, 2024 | Restricted Stock Vesting |
| Margaret Ancona Officer | Sep 16, 2024 | 11,538 | $321.02K | Aug 21, 2024 | Stock Bonus |
| Dale Muzzey Officer | Sep 11, 2024 | 2,100 | $54.96K | Sep 11, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | Sep 11, 2024 | 15,000 | $400.80K | Sep 11, 2024 | Restricted Stock Vesting |
| Heinrich Dreismann Director | Sep 9, 2024 | 10,000 | $270.00K | Sep 10, 2024 | stock bonus |
| Colleen F. Reitan Director | Sep 3, 2024 | 46,012 | $1.30M | Sep 3, 2024 | Restricted Stock Vesting |
| Rashmi Kumar Director | Aug 19, 2024 | 7,500 | $210.08K | Aug 19, 2024 | Restricted Stock Vesting |
| Daniel K. Spiegelman Director | Jun 4, 2024 | 3,788 | $83.53K | Jun 4, 2024 | Restricted Stock Vesting |
| Daniel K. Spiegelman Director | Jun 3, 2024 | 3,788 | $83.49K | Jun 3, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | May 15, 2024 | 75,000 | $1.88M | May 15, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | May 14, 2024 | 95,000 | $2.39M | May 14, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | May 13, 2024 | 57,844 | $1.45M | May 13, 2024 | Restricted Stock Vesting |
| Lee Nisley Newcomer Director | May 13, 2024 | 6,200 | $156.86K | May 13, 2024 | Restricted Stock Vesting |
| Bryan Riggsbee Richard Affiliate | Apr 10, 2024 | 75,000 | $1.50M | Apr 10, 2024 | Vested RSUs granted 3/15/2023 |